Vyleesi (bremelanotide) Approval Letter

FDA approved Vyleesi (bremelanotide) subcutaneous injection for acquired, generalized hypoactive sexual desire disorder in premenopausal women.

Not legal or medical advice.

This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.